Abstract
Sustained untreated hyperglycemia is associated with complications at molecular, cellular, and organ levels in the body that ultimately lead to comorbidities including cardiovascular-related pathologies, neuropathies, nephropathies, blindness, limb amputations, etc. Mature RBCs are unique in their structure and function; being without cellular organelles including nucleus and mitochondria, they are highly sensitive and responsive to the molecular changes in their microenvironment in general and elevated glucose in particular. They lack the ability to synthesize new proteins, replenish its enzyme-based antioxidant machinery, and replace any cellular components in the event of oxidative damage. Although they are dependent on glycolytic processing of glucose for their energy requirements, sustained exposure to hyperglycemia significantly impacts their structure as well as function and leads to early aging of the circulating RBCs with shortened lifespan. Loss of deformability due to hyperglycemia prohibits them to reversibly change their shape and squeeze through the microvasculature, a hallmark of RBC functionality for nutrient and gaseous exchanges. This mini-review of literature signifies the effect of hyperglycemia on RBCs in terms of eryptosis, lipid peroxidation in the cell membrane to compromise membrane integrity which significantly alters its deformity and coaguability, and adherence to endothelial surface leading loss of functionality and life-span.
Similar content being viewed by others
Abbreviations
- AGEs:
-
Advanced glycation end products
- Arg-P:
-
Arg-pyrimidine
- CEL:
-
Carboxyethyllysine
- CML:
-
Carboxymethylysine
- CP450:
-
Cytochrome P-450
- FAAD:
-
Fas-associated death domain
- FasL:
-
Fas ligand
- GLUT1:
-
Glucose transporter 1
- GLUT4:
-
Glucose transporter 4
- HSCs:
-
Hematopoietic stem cells
- LDH:
-
Lactate dehydrogenase
- MDA:
-
Malonyldialdehyde
- MCV:
-
Mean corpuscular volume
- Na+/K+-ATPase:
-
Na+/K+ adenosine triphosphatase (ATPase)
- ROS:
-
Reactive oxygen species
- RBCs:
-
Red blood cells
- WHO:
-
World Health Organization
References
World Health Organization. WHO global report on diabetes 2016. http://www.who.int/diabetes/global-report/.
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.
Lee PG, Halter JB. The pathophysiology of hyperglycemia in older adults: clinical considerations. Diabetes Care. 2017;40(4):444–52. https://doi.org/10.2337/dc16-1732.
Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002;288(20):2579–88. https://doi.org/10.1001/jama.288.20.2579.
Kaneto H, Katakami N, Matsuhisa M, Matsuoka T. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis. Mediat Inflamm. 2010;2010:453892. 11 pages
Robertson RP, Harmon J, Takahasi H. Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003;52(3):581–7. https://doi.org/10.2337/diabetes.52.3.581.
Leney SE, Tavare JM. The molecular basis of insulin-stimulated glucose uptake: signalling, trafficking and p2otential drug targets. J Endocrinol. 2009;203(1):1–18. https://doi.org/10.1677/JOE-09-0037.
Ebeling P, Koistinen HA, Koivisto VA. Hypothesis: Insulin-independent glucose transport regulates insulin sensitivity. FEBS Lett. 1998;436(3):301–3. https://doi.org/10.1016/S0014-5793(98)01149-1.
Campos C. Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med. 2012;124(6):90–7. https://doi.org/10.3810/pgm.2012.11.2615.
Arias CF, Arias CF. How do red blood cells know when to die? R Soc Open Sci. 2017;4(4):160850. https://doi.org/10.1098/rsos.160850.
Adamson JW. Regulation of red blood cell production. Am J Med. 1996;101(2):4S–6S. https://doi.org/10.1016/S0002-9343(96)00160-X.
Burrilla DR, Verneta A, Collinsa JJ, Silvera PA, Waya JC. Targeted erythropoietin selectively stimulates red blood cell expansion in vivo. PNAS. 2016;113(19):5245–50. https://doi.org/10.1073/pnas.1525388113.
Pries AR, Secomb TW, Gaehtgens P. Biophysical aspects of blood flow in the microvasculature. Cardiovasc Res. 1996;32(4):654–67. https://doi.org/10.1016/S0008-6363(96)00065-X.
Kholoussi N, Helwa I, Amara F. Red blood cells surface morphology in diabetic ketoacidosis. Middle East J Appl Sci. 2012;2(1):51–7.
Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989;264(35):21340–5.
Lutz HU, Bogdanova A. Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol. 2013;4:387. Pages 1–15
van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood. 2005;106(13):4034–42. https://doi.org/10.1182/blood-2005-04-1622.
Valentine WN, Paglia DE. The primary cause of hemolysis in enzymopathies of anaerobic glycolysis: a viewpoint. Blood Cells. 1980;6(4):819–29.
Mazzanti L, Faloia E, Rabini RA, Staffolani R, Kantar A, Fiorini R, et al. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem. 1992;25(1):41–6. https://doi.org/10.1016/0009-9120(92)80044-H.
Cohen RM, Franco RS, Joiner C. Is poor glycemic control associated with reduced red blood cell lifespan? Diabetes Care. 2004;27(4):1013–4. https://doi.org/10.2337/diacare.27.4.1013.
Huang Z, Liu Y, Mao Y, Chen W, Xiao Z, Yu Y. Relationship between glycated haemoglobin concentration and erythrocyte survival in type 2 diabetes mellitus determined by a modified carbon monoxide breath test. J Breath Res. 2017; https://doi.org/10.1088/1752-7163/aa9081.
Carruthers A, DeZutter J, Ganguly A, Devaskar SU. Will the original glucose transporter isoform please stand up! Am J Physiol Endocrinol Metab. 2009;297(4):E836–48. https://doi.org/10.1152/ajpendo.00496.2009.
Montel-Hagen A, Kinet S, Manel N, et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell. 2008;132:1039–48.
Montel-Hagen A, Blanc L, Boyer-Clavel M, Jacquet C, Vidal M, Sitbon M, et al. The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis. Blood. 2008;112:4729–38.
Vrhovac I, Breljak D, Sabolic I. Glucose transporters in the mammalian blood cells. Period Biol. 2014;116(2):131–8.
Zhang J-Z, Ismail-Beigi F. Activation of GLUT1 glucose transporter in human erythrocytes. Arch Biochem Biophys. 1998;365(1):86–92.
Hajjawi OS. Glucose transport in human red blood cells. Am J Biomed Life Sci. 2013;1(3):44–52.
Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Asp Med. 2013;34(2-3):121–38. https://doi.org/10.1016/j.mam.2012.07.001.
Hu X-J, Peng F, Zhou H-Q, Zhang Z-H, Cheng W-Y, Feng H-F. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta. 2000;1466(1-2):306–14. https://doi.org/10.1016/S0005-2736(00)00175-9.
Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem. 2005;15(5):195–202. https://doi.org/10.1159/000086406.
Fırat U, Kaya S, Çim A, Büyükbayram H, Gökalp O, Dal MS, et al. Increased caspase-3 immunoreactivity of erythrocytes in stz diabetic rats. Exp Diabetes Res. 2012;2012:316384. https://doi.org/10.1155/2012/316384.
Mandal D, Mazumder A, Das P, Kundu M, Basu J. Fas-, caspase 8-, and caspase 3-dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J Biol Chem. 2005;280(47):39460–7. https://doi.org/10.1074/jbc.M506928200.
Ghashghaeinia M, Cluitmans JCA, Akel A, Dreischer P, Toulany M, Köberle M, et al. The impact of erythrocyte age on eryptosis. Br J Haematol. 2012;157(5):606–14. https://doi.org/10.1111/j.1365-2141.2012.09100.x.
Lang E, Lang F. Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death. BioMed Res Int. 2015;2015:513518. 16 pages
Awasthi S, Gayathiri SK, Ramya R, Duraichelvan R, Dhason A, Saraswathi NT. Advanced glycation-modified human serum albumin evokes alterations in membrane and eryptosis in erythrocytes. Appl Biochem Biotechnol. 2015;177(5):1013–24. https://doi.org/10.1007/s12010-015-1793-x.
Maellaro E, Leoncini S, Moretti D, BelloItalo BD, Claudio T, De Felice C, et al. Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol. 2013;50(4):489–95. https://doi.org/10.1007/s00592-011-0274-0.
Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939–48. https://doi.org/10.1182/blood-2008-07-161166.
Himbert S, Alsop RJ, Rose M, Hertz L, Dhaliwal A, Moran-Mirabal JM, et al. The molecular structure of human red blood cell membranes from highly oriented, solid supported multi-lamellar membranes. Sci Rep. 2017;7:39661.
Lieberman M, Marks A, Peet A, Chansk M. Marks’ Basic Medical Biochemistry. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 805–26.
Campanella ME, Chu H, Low PS. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. PNAS. 2005;102(7):2402–7. https://doi.org/10.1073/pnas.0409741102.
Ferru E, Giger K, Pantaleo A, Campanella E, Grey J, Ritchie K, et al. Regulation of membrane-cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Blood. 2011;117(22):5998–6006. https://doi.org/10.1182/blood-2010-11-317024.
Cluitmans J, Gevi F, Siciliano A, Matte A, Leal J, De Franceschi L, et al. Red blood cell homeostasis: pharmacological interventions to explore biochemical, morphological and mechanical properties. Front Mol Biosci. 2016;3:10. https://doi.org/10.3389/fmolb.2016.00010.
Dzik WH. The air we breathe: three vital respiratory gases and the red blood cell: oxygen, nitric oxide, and carbon dioxide. Transfusion. 2011;51(4):676–85. https://doi.org/10.1111/j.1537-2995.2011.03114.x.
Morse EE, Kalache G, Wermino FG, Stockwell R. Increased electronic mean corpuscular volume induced by marked hyperglycemia. Ann Clin Lab Sci. 1981;11(2):184–7.
Nagai R, Deemer EK, Brock JW, Thorpe SR, Baynes JW. Effect of glucose concentration on formation of AGEs in erythrocytes in vitro. Ann New York Acad Sci. 2005;1043(1):146–50. https://doi.org/10.1196/annals.1333.018.
Reshamwala S, Patil N. Biochemical changes in erythrocyte membrane in uncontrolled type 2 diabetes mellitus. Indian J Biochem Biophys. 2005;42(4):250–3.
Jameson J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, et al. Harrison’s principles of internal medicine. 19th ed. New York: McGraw-Hill, Medical Publishers; 2015. p. 2423–30.
Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes. 1989;38(12):1539–43. https://doi.org/10.2337/diab.38.12.1539.
Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, et al. Effect of aging on A1C levels in individuals without diabetes. Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care. 2008;31(10):1991–6. https://doi.org/10.2337/dc08-0577.
Jain SK, Levinea SN, Duetta J, Hollie B. Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism. 1990;39(9):971–5. https://doi.org/10.1016/0026-0495(90)90310-9.
Viskupicova J, Blaskovic D, Galiniak S, Soszyński M, Bartosz G, Horakova L, et al. Effect of high glucose concentrations on human erythrocytes in vitro. Redox Biol. 2015;5:381–7. https://doi.org/10.1016/j.redox.2015.06.011.
Dianzani M, Barrera G. Pathology and physiology of lipid peroxidation and its carbonyl products. In: Álvarez S, Evelson P, editors. Free Radical Pathophysiology. Kerala: Transworld Research Network; 2008. p. 19–38. ISBN: 978-81-7895-311-3.
Blisard KS, Mieyal JJ. Characterization of the aniline hydroxylase activity of erythrocytes. J Biol Chem. 1979;254:5104–10.
Starke DW, Blisard KS, Mieyal JJ. Substrate specificity of the monooxygenase activity of hemoglobin. Mol Pharrnacol. 1984;25:467–75.
Edwards CJ, Fuller J. Oxidative stress in erythrocytes. Comp Haematol Int. 1996;6(1):24–31. https://doi.org/10.1007/BF00368098.
Mohanty JG, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014;5:84.
Pandey KB, Rizvi SI. Biomarkers of oxidative stress in red blood cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155(2):131–6. https://doi.org/10.5507/bp.2011.027.
Varashree BS, Bhat GP. Correlation of lipid peroxidation with glycated hemoglobin levels in diabetes mellitus. Online J Health Allied Sci. 2011;10(2):11.
Jain SK, Mohandas N, Clark M, Shohet SB. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration, and 51-Cr-survival of erythrocytes. Br J Haematol. 1983;53(2):247–55. https://doi.org/10.1111/j.1365-2141.1983.tb02018.x.
Rodrigo R, Bächler JP, Araya J, Prat H, Passalacqua W. Relationship between (Na+K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects. Mol Cell Biochem. 2007;303(1-2):73–81. https://doi.org/10.1007/s11010-007-9457-y.
Cazzola R, Rondanelli M, Russo-Volpe S, Ferrari E, Cestaro B. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res. 2004;45(10):1846–51. https://doi.org/10.1194/jlr.M300509-JLR200.
Bravi MC, Armiento A, Laurenti O, Cassone-Faldetta M, De Luca O, Moretti A, et al. Insulin decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2006;55(5):691–5. https://doi.org/10.1016/j.metabol.2006.01.003.
Sompong W, Cheng H, Adisakwattana S. Protective effects of ferulic acid on high glucose-induced protein glycation, lipid peroxidation, and membrane ion pump activity in human erythrocytes. PLoS One. 2015;10(6):e0129495. https://doi.org/10.1371/journal.pone.0129495.
Iannello S, Milazzo P, Belfiore F. Animal and human tissue Na, K-ATPase in obesity and diabetes: a new proposed enzyme regulation. Am J Med Sci. 2007;333:1–9.
Srivatsan R, Das S, Gadde R, Manoj-Kumar K, Taduri S, Rao N. Antioxidants and lipid peroxidation status in diabetic patients with and without complications. Arch Iran Med. 2009;12:121–7.
Nans A, Mohandas N, Stokes DL. Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography. Biophys J. 2011;101(10):2341–50. https://doi.org/10.1016/j.bpj.2011.09.050.
Li J, Lykotrafit G, Dao M, Suresh S. Cytoskeletal dynamics of human erythrocyte. PNAS. 2007;104(12):4937–42. https://doi.org/10.1073/pnas.0700257104.
Simmons D. Increased red cell count in diabetes and pre-diabetes. Diabetes Res Clin Pract. 2010;90(3):e50–3. https://doi.org/10.1016/j.diabres.2010.07.005.
Babu N, Singh M. Influence of hyperglycemia on aggregation, deformability and shape parameters of erythrocytes. Clin Hemorheol Microcirc. 2004;31:273–80.
van Buys A, van Rooy M-J, Soma P, Papendorp DV, Lipinski B, Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol. 2013;12(1):25. https://doi.org/10.1186/1475-2840-12-25.
Agrawal R, Smart T, Nobre-Cardoso J, Richards C, Bhatnagar R, Tufail A, et al. Assessment of red blood cell deformability in type 2 diabetes mellitus and diabetic retinopathy by dual optical tweezers stretching technique. Sci Rep. 2016;6(1):15873.
Elshennawy ATM. Effect of gestational diabetes on gross morphology, histology and histochemistry of human placenta. Endocrinol Metab Syndr. 2016;5:1.
Kamana KC, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(suppl 2):14–20.
Gioia S, Cerekja A, Larciprete G, Vallone C, Demaliaj E, Evangelista MT, et al. Gestational diabetes: is it linked to platelets hyperactivity? Platelets. 2009;20(2):140–1. https://doi.org/10.1080/09537100802630062.
Min Y, Ghebremeskel K, Lowy C, Thomas B, Crawford MA. Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. Diabetologia. 2004;47(1):75–81. https://doi.org/10.1007/s00125-003-1275-5.
Min Y, Nam J-H, Ghebremeskel K, Kim A, Crawford M. A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study. Diabetes Res Clin Pract. 2006;73(2):178–83. https://doi.org/10.1016/j.diabres.2006.01.003.
Taschereau-Charron A, Da Silva MS, Bilodeau J-F, Morisset A-S, Julien P, Rudkowska I. Alterations of fatty acid profiles in gestational diabetes and influence of the diet. Maturitas. 2017;99:98–104. https://doi.org/10.1016/j.maturitas.2017.01.014.
Moretti N, Rabini RA, Nanetti L, Grechi G, Curzi MC, Cester N, et al. Sialic acid content in erythrocyte membranes from pregnant women affected by gestational diabetes. Metabolism. 2002;51(5):605–8. https://doi.org/10.1053/meta.2002.32015.
Acknowledgements
We thank SRC for supporting this student research project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Not applicable.
Rights and permissions
About this article
Cite this article
Mamoun Rajab, A., Haider, K.H. Hyperglycemia and RBCs: too sweet to survive. Int J Diabetes Dev Ctries 38, 357–365 (2018). https://doi.org/10.1007/s13410-018-0613-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-018-0613-6